Company: RGNT
Filing Date: 2025-03-11
Form Type: F-1
Source: 0001213900-25-022350
Chunk: 250

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-03-11
Form: F-1
Chunk 250
---
30, 2024, are not necessarily indicative of the results to be expected for the full year ending December
31, 2024, or any other future interim or annual periods. These unaudited interim condensed financial statements should be read in conjunction
with the audited financial statements and accompanying notes as of and for the year ended December 31, 2023. The significant accounting
policies applied in the annual financial statements of the Company as of and for the year ended December 31, 2023 are applied consistently
in these interim condensed financial statements.

<div align='center'>F-7</div>

REGENTIS BIOMATERIALS LTD.

NOTES TO THE UNAUDITED INTERIM CONDENSED FINANCIAL STATEMENTS

U.S. dollars in thousands, except share and per share data

| NOTE 2: | SIGNIFICANT ACCOUNTING POLICIES (Cont.) |

| b. | Use of estimates in preparation of financial statements: |

The preparation of financial statements
in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets
and liabilities as of the dates of the financial statements and the reported amounts of expenses during the reporting period. Management
believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made.
Actual results could differ from those estimates.

| c. | Significant Accounting Policies: |

The significant accounting policies followed
in the preparation of these unaudited interim condensed financial statements are applied consistently with the significant accounting
policies applied in the Company’s latest annual financial statements as of and for the period ended December 31, 2023.

| d. | Basic and diluted loss per share: |

The Company’s convertible preferred
shares are participating securities. As the Company has participating securities, the Company compute earnings per share using the two-class method.
Under the two-class method, net profit/(loss) is allocated between ordinary shares and other participating securities based
on their participating rights. The Company’s participating securities do not contractually require the holders of such shares to participate
in the Company’s losses. As such, net loss for the period presented were not allocated to the Company’s participating securities.

The profit/(loss) and the weighted average number of shares
used in computing basic and diluted net profit/(loss) per share is as follows:

| Numerator:                                                        |     | Six months ended 
 June 30,         
 2024             |